SPM-002

N/A

Report date: 2024/10/30 15:18:10
NMEFirst In Class

Base Information

Drug NameSPM-002
Drug Alias NameSPM-002SPM002
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSPIMA Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesSPIMA Therapeutics
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A